Pharma News India
The move is expected to make the medicines cheaper.
New Delhi, March 1, 2013: Swiss drug company Roche has entered into an agreement with Emcure Pharma for local manufacturing of its two patented cancer drugs. It is expected that the technology transfer project will make the medicines cheaper.
The pharma company has received the approval from US drug authorities.
Ahmedabad, February 27, 2013: Zydus Cadila has secured a tentative approval from the US authorities for the Doxepin Hcl tablets. The company plans to launch the drug in 2020.
Exports from Indian pharmaceutical companies are expected to touch Rs 75,000 crore in 2012-13.
Chennai, February 21, 2013: Pharmaceutical exports of Indian companies are expected to register an increase of over 25 per cent in 2012-13 to reach Rs 75,000 crore.
The agreement is for developing and marketing generic versions of three high-value insulin products.
Mumbai, February 15, 2013: Biocon has inked a pact with American generic drugmaker Mylan for developing and marketing generic versions of three high-value insulin products for the developed and emerging markets.
The approval enables the company to export products from these facilities to Australia.
New Delhi, February 14, 2013: Venus Remedies has received approval from the Australian authorities for four of its facilities. The approval is expected to enable to the company to export its products manufactured at these facilities to the Australian market.